Vir Biotechnology, Inc. (VIR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$11.39-0.52%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · VIR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | |
|---|---|---|---|
| Revenues | |||
| Revenues | 303.2 | 68.6 | 74.2 |
| Total Revenues | 303.2 | 68.6 | 74.2 |
| Cost of Revenues | — | 0.0 | 0.8 |
| Operating Expenses & Income | |||
| Selling, General & Admin | 99.4 | 92.1 | 119.0 |
| R&D Expenses | 484.0 | 456.0 | 506.5 |
| Operating Income | (280.2) | (479.3) | (587.2) |
| Earnings from Continuing Operations | |||
| Interest & Investment Income | 33.3 | 40.2 | 71.8 |
| Other Non-Operating Income / Expenses | 28.9 | 41.6 | 64.1 |
| EBT, Incl. Unusual Items | (251.3) | (437.8) | (523.1) |
| Income Tax Expense | 0.4 | 0.2 | (1.1) |
| Net Income | |||
| Net Income | (251.7) | (438.0) | (522.0) |
| Per Share | |||
| Basic EPS | (1.50) | (3.16) | (3.83) |
| Diluted EPS | (1.49) | (3.16) | (3.83) |
| Revenue per Share | 1.80 | — | — |
| Basic Weighted Avg Shares | 167.7 | 138.5 | 136.2 |
| Diluted Weighted Avg Shares | 168.9 | 138.5 | 136.2 |
| Supplemental | |||
| EBITDA | — | (467.6) | (572.6) |
| EBIT | (280.2) | (479.3) | (587.2) |
| Effective Tax Rate | -0.2% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.